📣 Roche News Snippet: » CT-996 led to significant weight loss (-7.3%) after 4 weeks 🆚 placebo (-1.2%) » data supports once-daily oral dosing regimen » Safety profile was similar to other GLP-1 drugs; no unexpected safety issues observed
Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.